The Senate Appropriations Committee gives FDA a boost for fiscal 2012 that likely will stick, thanks to the recent debt ceiling compromise.

Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.